University of Iowa Health Care News Release
Aug. 23, 2005
Heart Attack And Stroke Prevention Study Invites Participants
People ages 45 to 75 who are at high risk for a heart attack or stroke are invited to participate in a University of Iowa study designed to prevent these life-threatening events.
The study will evaluate whether use of an investigational medication to raise HDL (good) cholesterol will prevent heart attacks and strokes when combined with an approved medication to lower LDL (bad) cholesterol.
Eligible participants may qualify for the study if they have had any of the following: heart attack, chest pain, heart-related surgery, stroke or diabetes.
The study will last five years and involve approximately 17 to 20 visits to UI Hospitals and Clinics over that time period. Eligible participants randomly will be assigned to take the two-medication combination or only the medication for lowering LDL cholesterol. The medication(s) will be provided at no cost.
The study visits will involve, also at no cost to participants, physical exams, electrocardiograms, and blood and laboratory evaluations. Compensation for travel and parking is available.
Approximately 200 people will take part in the study at the UI. The study involves nearly 250 sites in North America, Europe and Australia, and approximately 13,000 individuals are expected to participate.
The UI portion of the study is led by Jennifer Robinson, M.D., associate professor of epidemiology in the UI College of Public Health and director of the UI Lipid Research Center.
For more information, call the UI Lipid Research Center toll-free at 800-887-6917 or locally at 319-384-5048.
STORY SOURCE: University of Iowa Health Science Relations, 5137 Westlawn, Iowa City, Iowa 52242-1178
Interested Study Participants: UI Lipid Research Center, 800-887-6917 or 319-384-5048
MEDIA CONTACT: Becky Soglin, 319 335-6660 email@example.com